← Back

Wire · opportunities

Finding drug targets in the tissue context with spatial biology

Published

17 August 2026

Topic

opportunities

◆ Sectors

Drug DiscoveryBiotech

◆ Source

Read at drugdiscoverynews.com →

◆ Verified

Fusion42 · 17 August 2026 · Fusion42 review

Spatial biology enhances drug target discovery by preserving tissue context, enabling identification of both cell-type-specific and location-dependent targets that bulk and single-cell sequencing alone cannot reveal.

This Wire brief sits within Fusion42's coverage of Drug Discovery and Biotech.

◆ ◆ The Wire takeaway

Biotech founders using drug discovery need to integrate spatial data to refine and validate targets beyond single-cell approaches. Your next screening pipeline should layer spatial biology onto genetics to avoid missing location-specific therapeutic targets.

◆ Coverage

1 source · 17 Aug 2026

◆ Related on Wire

◆ Topics

Drug DiscoveryBiotechspatial-biologydrug-discoverysingle-cell-sequencingtherapeutic-targetsdisease-mapping